Deficient candida-specific T-helper 17 response during sepsis

Journal of Infectious Diseases

Volumn 206, Issue 11, 2012, Pages 1798-1802

  Van De Veerdonk, Frank L ^a   Mouktaroudi, Maria ^b   Ramakers, Bart P ^a   Pistiki, Aikaterini ^b   Pickkers, Peter ^a   Van Der Meer, Jos W M ^a   Netea, Mihai G ^a   Giamarellos Bourboulis, Evangelos J ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANDIDA ALBICANS; CANDIDEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; GRAM NEGATIVE SEPSIS; GREECE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTION RISK; INFECTION SENSITIVITY; INTENSIVE CARE UNIT; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TH17 CELL;

BACTERIAL INFECTIONS; CANDIDA ALBICANS; CANDIDIASIS; CYTOKINES; ENDOTOXEMIA; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; RISK FACTORS; SEPSIS; TH17 CELLS;

EID: 84869068387     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis596     Document Type: Article

References (14)

1. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39:309-17.
2. Gow NA, van de Veerdonk FL, Brown AJ, Netea MG. Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat Rev Microbiol 2012; 10:112-22.
3. McGeachy MJ, Cua DJ. Th17 cell differentiation: the long and winding road. Immunity 2008; 28:445-53.
4. Giamarellos-Bourboulis EJ, van de Veerdonk FL, Mouktaroudi M, et al. Inhibition of caspase-1 activation in gram-negative sepsis and experimental endotoxemia. Crit Care 2011; 15:R27.
5. Ramakers BP, Riksen NP, van den Broek P, et al. Circulating adenosine increases during human experimental endotoxemia but blockade of its receptor does not influence the immune response and subsequent organ injury. Crit Care 2011; 15:R3.
6. Lehrer RI, Cline MJ. Interaction of Candida albicans with human leukocytes and serum. J Bacteriol 1969; 98:996-1004.
7. van der Graaf CA, Netea MG, Verschueren I, van der Meer JW, Kullberg BJ. Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae. Infect Immun 2005; 73:7458-64.
8. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007; 8:942-9.
9. Milner JD, Brenchley JM, Laurence A, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008; 452:773-6.
10. van de Veerdonk FL, Plantinga TS, Hoischen A, et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med 2011; 365:54-61.
11. van de Veerdonk FL, Marijnissen RJ, Joosten LA, et al. Milder clinical hyperimmunoglobulin E syndrome phenotype is associated with partial interleukin-17 deficiency. Clin Exp Immunol 2010; 159:57-64.
12. Aujla SJ, Chan YR, Zheng M, et al. IL-22 mediates mucosal host defense against gram-negative bacterial pneumonia. Nat Med 2008; 14:275-81.
13. Chung Y, Chang SH, Martinez GJ, et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 2009; 30:576-87.
14. Osuka A, Hanschen M, Stoecklein V, Lederer JA. A protective role for inflammasome activation following injury. Shock 2012; 37: 47-55.